CDK2 and breast cancer: Herein, we show that this plasmid DNA-based scaffold is capable of delivering bioactive DNA encoding for shRNA leading to the successful silencing of its target gene (Cdk2) and resulting in the disruption of the cell cycle, as well as a reduction in the proliferation and viability of MCF-7 human breast cancer cells.